What is the next step in evaluating a patient with amenorrhea who has normal prolactin, low TSH due to levothyroxine suppression, and normal free thyroxine levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Next Step: Measure LH, FSH, and Estradiol

With normal prolactin and thyroid function confirmed (recognizing the low TSH is iatrogenic from levothyroxine suppression therapy with normal free T4), the next critical step is to measure LH, FSH, and estradiol (E2) levels to differentiate between the major causes of amenorrhea. 1

Rationale for This Approach

The 2017 Endocrine Society guideline on functional hypothalamic amenorrhea provides clear direction: after excluding pregnancy and ruling out hyperprolactinemia and thyroid dysfunction, measuring FSH, LH, and E2 is essential to distinguish between functional hypothalamic amenorrhea (FHA), ovarian insufficiency, and other causes 1.

Key Diagnostic Patterns to Identify

The hormone pattern will guide your diagnosis:

  • Functional Hypothalamic Amenorrhea (FHA): Low or low-normal LH (<10 IU/L), normal FSH (<10 IU/L), LH/FSH ratio ~1, E2 <50 pg/mL, progesterone <1 ng/mL 1

  • Ovarian Insufficiency/Menopause: Elevated FSH and LH (>15 IU/L), FSH > LH, E2 <50 pg/mL, progesterone <1 ng/mL 1

  • PCOS: LH <15 IU/L, FSH <10 IU/L, LH > FSH ratio, E2 <50 pg/mL, progesterone <1 ng/mL 1

  • Organic Hypothalamic Amenorrhea: Very low or undetectable LH and FSH, suggesting pituitary/hypothalamic tumors or infiltrative lesions 1

Additional Testing to Consider

Add AMH (anti-Müllerian hormone) to your panel 1. The guideline specifically recommends AMH as part of the initial endocrine evaluation, as it helps assess ovarian reserve (low <0.5 ng/mL in ovarian insufficiency, normal or elevated in PCOS).

If Clinical Hyperandrogenism Present

Only if there are signs of androgen excess (hirsutism, acne, male pattern alopecia), add:

  • Total testosterone
  • DHEA-S
  • 8 AM 17-hydroxyprogesterone (if suspecting late-onset CAH) 1

Important Caveat About the Low TSH

Your patient's low TSH with normal free T4 is expected and appropriate if she's on levothyroxine for thyroid cancer suppression or other indication requiring TSH suppression 2. This is iatrogenic, not pathologic. The guideline notes that in true FHA, TSH would be in the lower range of normal, not suppressed 1. Don't let the suppressed TSH distract from the amenorrhea workup—the normal free T4 confirms adequate thyroid hormone replacement.

Why This Pattern-Based Approach Matters

The pattern of hormone levels is more critical than absolute values 1. A single hormone abnormality rarely provides the diagnosis. For example, normal LH and FSH can be confusing in FHA since E2 is low, but this combination is characteristic of the condition 1. Very low gonadotropins suggest organic hypothalamic disease requiring brain imaging, while elevated gonadotropins indicate ovarian failure requiring different management entirely.

Clinical Implications Drive Testing

  • FHA patients need evaluation for eating disorders, excessive exercise, stress, and bone density assessment 1
  • Ovarian insufficiency patients may maintain unpredictable ovarian function and need hormone replacement until average age of menopause
  • PCOS patients require metabolic screening for glucose intolerance and dyslipidemia 1

The next laboratory draw should include: LH, FSH, estradiol, and AMH as the core panel 1.

References

Related Questions

What is the best approach to testing for pregnancy in a woman who has had amenorrhea for six months?
What is the appropriate workup for a 41‑year‑old woman with a negative pregnancy test presenting with amenorrhea?
Which hormone labs should be ordered for a 42-year-old woman with secondary amenorrhea to evaluate her hormonal status and determine the cause of her missed menstrual cycles?
How should a 55-year-old woman with four years of amenorrhea be evaluated and managed regarding menopause?
In a 36-year-old woman with secondary amenorrhea for more than 2–3 months, intermittent spotting, low follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) (~2–3 IU/L) and low estradiol (~73 pg/mL), what is the appropriate evaluation and management?
In a patient with papillary thyroid carcinoma who is receiving thyroid‑stimulating hormone (TSH) suppression therapy resulting in a suppressed TSH, could the low TSH be causing her amenorrhea?
Can a CT coronary angiogram with coronary artery calcium scoring evaluate for myocardial (cardiac) bridging?
What is the recommended evaluation and management for a patient with hyperinsulinemia?
Should an emergent computed tomography angiography (CTA) of the head and neck be obtained to evaluate for posterior fossa lesions or arterial interruption causing severe vertigo and syncope?
Why should I check a uric acid level?
What is the best next step in management for a 7-year-old girl with new-onset nocturnal enuresis, no dysuria, fever, hematuria, normal physical examination, and normal vital signs?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.